Lung Cancer | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Targeted Therapy for Lung Cancer - a podcast by Dr Neil Love
from 2021-04-17T12:00
::
::
Featuring perspectives from Drs Joel W Neal and Paul K Paik on the following topics:
- Introduction (0:00)
- Case: A 67-year-old man, never smoker with symptomatic metastatic adenosquamous carcinoma of the lung (1:33)
- Targeting ROS1 rearrangements in non-small cell lung cancer (NSCLC) (9:07)
- EGFR exon 19 deletion and exon 21 (L858R) point mutation in NSCLC (11:17)
- Recent data with agents targeting EGFR exon 20 insertions in NSCLC (28:22)
- Efficacy and safety of agents targeting HER2 amplification/mutation (31:56)
- ALK rearrangements as a therapeutic target in NSCLC (38:07)
- Targeting NTRK fusions in NSCLC (41:46)
- Available data with RET inhibitors in NSCLC (43:50)
- MET Exon 14 skipping mutations in NSCLC (46:36)
- Emerging data with agents targeting KRAS G12C mutation in NSCLC (51:47)
CME information and select publications
Further episodes of Research To Practice | Oncology Videos
Further podcasts by Dr Neil Love
Website of Dr Neil Love